Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update for vebreltinib as neoadjuvant therapy in MET exon 14 skipping mutant non-small cell lung cancer (Stage IIA-IIIB, N2); …
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer [NA]
This Clinical Trials update describes a decision-aid intervention intended to improve decision-making for patients with non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Safety and Efficacy of Lorbrena
Pfizer's clinical trial update reports safety and efficacy data for lorlatinib (Lorbrena) in non-small cell lung cancer. The study status is…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers [Phase 1]
Phase 1 trial evaluating TAK-676 in combination with pembrolizumab after radiation therapy across several cancers; the study completed and p…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of FF-10832 in combination with pembrolizumab for advanced urothelial carci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
A clinical trial (NCT05965557) sponsored by Geneplus-Beijing Co. Ltd is investigating predictive biomarkers for the effectiveness of neoadju…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment [Phase 1]
Phase 1 trial update on LOXO-260 for RET-altered cancers that progressed after prior treatment, including Non-Small Cell Lung Cancer and Thy…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC) [Phase 2]
This is a Phase 2 clinical trial update for MORAb-202 in previously treated metastatic non-small cell lung cancer with adenocarcinoma histol…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial investigating bozitinib in combination with chemotherapy as a radical treatment for MET-altered non-small cell lung…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC [Phase 2]
A Phase 2 trial called DISCERN is evaluating dual versus single immune checkpoint blockade in PD-L1 negative non-small cell lung cancer. The…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen
A clinical trial update investigating how patient-reported outcome measurements influence outcomes in first-line non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC [Phase 2]
A Phase 2 clinical trial evaluating the combination of osimertinib and S-1 in treatment-resistant EGFR-mutant non-small cell lung cancer; th…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: PET/CT for Trop2 ADC Response Evaluation NSCLC
A clinical trial is recruiting to evaluate a Trop2-targeting antibody-drug conjugate for assessing treatment response in non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
An update on IMM-1-104's Phase 1/2a trial in advanced or metastatic solid tumors shows the study is currently active but not recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-09-02Clinical Trial Update: Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures [Phase 2]
Phase 2 trial targeting MDMD and PD-1 in tumors with tertiary lymphoid structures has been withdrawn; the study covered soft tissue sarcoma,…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Impact of Surgical Approach on Adaptation of Posture-respiratory Coupling [NA]
This clinical trial update reports on a study examining how the surgical approach affects adaptation of posture-respiratory coupling in pati…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593) [Phase 4]
This Phase 4 trial evaluated the safety of pembrolizumab in patients with unresectable or metastatic melanoma or non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Clinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLC [Phase 3]
Phase 3 clinical trial evaluating the combination of savolitinib and osimertinib for EGFR-mutant, MET-amplified non-small cell lung cancer; …
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors [Phase 1]
Phase 1 study of MEM-288 oncolytic virus in advanced solid tumors, evaluating MEM-288 alone and in combination with standard-of-care therapy…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating WSD0922-FU in patients with EGFR-mutant, advanced non-small cell lung cancer is ongoing and currently …
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR) [Phase 2]
This Phase 2 trial investigates preoperative amivantamab, with or without carboplatin/pemetrexed, in patients with resectable EGFR-mutant no…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7) [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study of DZD6008 in combination therapy for locally advanced or metastatic EGFR-mutant non-small cell …
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation [Phase 2]
Phase 2 trial of Pyrotinib in advanced non-small cell lung cancer with HER2 mutation has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies [Phase 1]
The Phase 1 study evaluating AB308 in combination with AB122 in participants with advanced malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC） [Phase 3]
Phase 3 clinical trial update for JS001sc or JS001 with chemotherapy in relapsed or metastatic non-squamous non-small cell lung cancer; the …